SecBot SecBot

OACC

Oaktree Acquisition Corp. III Life Sciences
Nasdaq· Blank Checks· Inc. E9· CIK 0002029769 Traditional Finance
$10.68 −0.03 (−0.28%)
Oct 26 4:00 PM ET · prev $10.71
Market cap
$263.8M
Micro cap
Next earnings
Nov 16
in 20 days
1 year
+0.4%
from $10.64 · Oct 28
30 days
−0.9%
from $10.78
52-week range
$10.54–10.93
−2% from high · low Nov 20
Avg volume 20D
48.4K
Oct 5 spike 280.3K
Short interest
193
+1.1%
Days to cover
1.0
at average volume
Insider net
$0
no open-market trades · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
6
analyzed by SecBot
SecBot read BEARISH 6 reports · 90 days
Balance 5 bearish · 0 bullish · 1 neutral oldest → newest, height = score
Avg score ·High conf. 5/6 ·Next Earnings date, Nov 16, 2026

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersNO TRADES

    No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.

  • InstitutionsMIXED

    Q2 2026: 2 added (0 new), 1 trimmed or exited.

  • Short sellersSTEADY

    Short interest +1.1% to 193 shares. 1.0 days to cover.

  • TrendDOWNTREND

    1% below its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
Verition Fund Management LLCADD470,342$5.0M
Schonfeld Strategic Advisors LLCADD144,677$1.5M
UBS Group AGNEAR_EXIT1,580$16.9K

Quarterly 13F filings are due 45 days after each quarter ends.

Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Recent

Insider ledger

Form 4
$0
open-market buys or sells · 12 mo
DateInsiderTypeValue
Oct 23, 2026
Oaktree Acquisition Holdings III LS, LLC
10%+ Owner
CONVERT4,798,758 sh
Oct 23, 2026
Oaktree Acquisition Holdings III LS, LLC
10%+ Owner
CONVERT4,798,758 sh

Earnings setup

Estimates
Nov 16
reports in 20 days
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00

Short side

FINRA· Oct 15, 2026
193
shares short
+1.1%
vs prior settlement
1.0
days to cover
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 26, 2026 SEC
Oaktree Acquisition Corp. III Life Sciences (OACC) held an extraordinary general meeting on October 23, 2026, where…
8-K — Impact 6/10
Oct 23, 2026 Insider
Oaktree Acquisition Holdings III LS, LLC acquired 4,798,758 shares
10%+ Owner
Oct 23, 2026 Insider
Oaktree Acquisition Holdings III LS, LLC disposed of 4,798,758 shares
10%+ Owner
Oct 16, 2026 SEC
Oaktree Acquisition Corp. III Life Sciences (OACC) postponed its extraordinary general meeting from October 16 to…
DEFA14A — Impact 5/10
Oct 16, 2026 SEC
Oaktree Acquisition Corp. III Life Sciences postponed its extraordinary general meeting from October 16, 2026 to…
8-K — Impact 5/10
Aug 10, 2026 Earnings calendar
OACC Q2 2026 Earnings Scheduled — 2026-08-10
Jun 30, 2026 Inst.
Verition Fund Management LLC — ADD
470,342 shares ($5.0M)
Jun 30, 2026 Inst.
Schonfeld Strategic Advisors LLC — ADD
144,677 shares ($1.5M)

SecBot reports

6 filings · 0 bullish · 5 bearish · 1 neutral
All OACC filing & press-release reports (6)